Andrew Wilber

Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection.

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

Dynamic gene expression after systemic delivery of plasmid DNA as determined by in vivo bioluminescence imaging.

RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.

Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon.

Harnessing a high cargo-capacity transposon for genetic applications in vertebrates.

Messenger RNA as a source of transposase for sleeping beauty transposon-mediated correction of hereditary tyrosinemia type I.

Efficient and stable transgene expression in human embryonic stem cells using transposon-mediated gene transfer.

A facile method for somatic, lifelong manipulation of multiple genes in the mouse liver.

Liver-directed gene therapy using the sleeping beauty transposon system.

DNA transposons for modification of human primary T lymphocytes.

Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons.

Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.

Roles of inflammation in cancer initiation, progression, and metastasis.

Cytotoxicity associated with artemis overexpression after lentiviral vector-mediated gene transfer.

A zinc-finger transcriptional activator designed to interact with the gamma-globin gene promoters enhances fetal hemoglobin production in primary human adult erythroblasts.

Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.

Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.

Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase.

Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities.

A live-attenuated HSV-2 ICP0 virus elicits 10 to 100 times greater protection against genital herpes than a glycoprotein D subunit vaccine.

Efficient non-viral integration and stable gene expression in multipotent adult progenitor cells.

Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone.

Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells.

Novel model for basaloid triple-negative breast cancer: behavior in vivo and response to therapy.

Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain.

Potentially therapeutic levels of anti-sickling globin gene expression following lentivirus-mediated gene transfer in sickle cell disease bone marrow CD34+ cells.

Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.

A system for creating stable cell lines that express a gene of interest from a bidirectional and regulatable herpes simplex virus type 1 promoter.

Partial nephrectomy for T2 renal masses: contemporary trends and oncologic efficacy.

Exploiting natural anti-tumor immunity for metastatic renal cell carcinoma.

Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells.

Long noncoding RNA Saf and splicing factor 45 increase soluble Fas and resistance to apoptosis.

Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death.

Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis.